Billionaire entrepreneur Elon Musk’s brain-chip startup Neuralink stated on Tuesday that it has obtained approval from an unbiased evaluation board to begin the primary human... Read More
Chicago: An experimental Alzheimer’s drug developed by Eli Lilly and Co slowed cognitive decline by 35% in a intently watched, late-stage trial, the corporate mentioned... Read More